SwissTAVI Registry
SwissTAVI Registry: Prospective, National, Multi-Center Registry of Patients Undergoing Transcatheter Aortic Valve Implantation
Insel Gruppe AG, University Hospital Bern
20,000 participants
Feb 1, 2011
OBSERVATIONAL
Conditions
Summary
The purpose of this prospective multi-center, observational national registry in Switzerland is to obtain clinical baseline, procedural and follow-up data of all patients treated with TAVI in Switzerland and to assess short, mid- and long-term clinical outcome data of the CE approved devices. All centers in Switzerland implanting the CE approved devices for TAVI will be invited to include patients in the registry. Each site will collect baseline and procedural data as well as clinical outcome data up to five years.
Eligibility
Inclusion Criteria3
- Native aortic valve stenosis
- Native aortic valve regurgitation
- Degenerated aortic bioprosthesis requiring treatment
Exclusion Criteria3
- Patients refuses informed consent to participate in the registry
- Contraindication for TAVI
- High probability of non-adherence to the follow up - requirements
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Minimal Invasive Implantation of a biological prosthesis in Aortic Position
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01368250